Company Reinforces its Commitment to Achieving Net-Zero Emissions and Supporting Decarbonization Across Operations by Joining Health Sector Climate Pledge

FRANKLIN LAKES, N.J. (Dec. 20, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was recognized during the 2023 United Nations Climate Change Conference (COP28) by the U.S. Department of Health and Human Services (HHS) for the company’s public commitments to decarbonize its operations and improve resilience in the face of climate change.

The pledge reinforces BD’s commitment to reducing greenhouse gas emissions (GHG) as part of its 2030+ environmental, social and governance (ESG) goals, and calls for health care companies across the U.S. to reduce GHG emissions by 50 percent by 2030 and achieve net zero emissions by 2050.

“By joining the White House-HHS Health Sector climate pledge, we are reaffirming our commitment to achieving net-zero emissions, and working toward growth of our business while supporting our communities and society for generations to come,” said Maureen Mazurek, chief sustainability and environmental, health and safety officer at BD. “We are partnering with stakeholders to improve our environmental footprint, build resilience in our operations and supply chain, and ultimately work toward successfully achieving our 2030+ ESG goals.”

BD has previously committed to reducing emissions by joining the United Nations Race to Zero, via the Business Ambition for 1.5°C and Science Based Targets initiative (SBTi). The company continues to address its environmental footprint, making progress toward its 2040 carbon neutral goal by reducing its scope 1 and 2 GHG emissions by 10 percent in Fiscal Year 2022 (from a Fiscal Year 2019 baseline), and increasing the number of the company’s sites using renewable electricity.

The company’s progress in achieving climate resilience across its value chain is also demonstrated by its partnerships with health systems, regulated waste management companies and recyclers in the U.S., Brazil, Denmark, Australia and New Zealand to explore circular economy solutions for managing BD products at end of life.

A September 2021 consensus statement from more than 200 medical journals named climate change the number one threat to global public health, exposing millions of people in the United States to harm every year — with disproportionate impacts on communities that are often already the victims of longstanding discrimination — through increases in extreme heat waves, wildfires, flooding, vector-borne diseases and other factors that worsen chronic health conditions. The health care sector also contributes to climate change itself, accounting for approximately 8.5 percent of U.S. domestic emissions.

To learn more about BD’s commitment to addressing climate change, view the company’s FY 2022 ESG Report.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

About HHS Office of Climate Change and Health Equity
The HHS Office of Climate Change and Health Equity (OCCHE), part of the Office of the Assistant Secretary for Health, developed the White House/HHS Health Sector Climate Pledge to help focus industry response to climate challenges. In addition to reducing their carbon footprint, more than 130 prominent health company signatories also commit to producing detailed plans to prepare their facilities for both chronic and acute catastrophic climate impacts.

Contacts:

Media:
Jessica Offerjost
BD Public Relations
201.258.0964
jessica.offerjost@bd.com

Investors:
Adam Reiffe
Sr. Director, Investor Relations
201.847.6927
adam.reiffe@bd.com